This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

WebMD Launches Medscape Germany

Stocks in this article: WBMD





NEW YORK, Oct. 19, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, announced today the launch of Medscape Germany ( www.medscapedeutschland.de), a service designed to provide physicians credible information and high-quality education tailored to the needs of German physicians and health care professionals.

Medscape Germany will be available to more than 300,000 physicians in the country, offering registered users free, unlimited access to clinical information and resources. The site draws upon the extensive experience of medscape.com in delivering online information to a physician audience. The site covers 15 of the most important specialty and condition areas and will include perspectives from world-renowned German specialists.  

"Every day, physicians around the world have come to rely on Medscape as a trusted resource that helps them stay informed, learn, and make optimal decisions for their patients," said Steven Zatz, MD, Executive Vice President for WebMD Professional Services. "Our new site is designed to address the information needs of busy German medical practitioners and to facilitate interactions among colleagues as they look to incorporate new approaches into their clinical practices."

Many European physicians are already familiar with and access Medscape, offering a strong base from which to build specialized services into major markets such as Germany. Medscape Germany will have its own dedicated editorial team and national advisors to develop the in-depth content.   

"This site has been developed for German physicians by a German editorial team," said Dr. Zatz. "What has been created is a unique destination where physicians will consistently find accurate and high-quality content that is supported by market-specific, balanced points of view."

Janssen, a research-based pharmaceutical company, is the charter supporter of multiple areas of the site, including a section devoted to helping German physicians manage their daily practice. This section reflects a partnership approach to helping physicians develop sustainable solutions for patient care, and can be found at praxis.medscapemedizin.de.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,471.37 -207.33 -1.17%
S&P 500 2,036.82 -20.27 -0.99%
NASDAQ 4,707.2080 -64.5550 -1.35%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs